Will a new US-led IP empire in India put access to medicines at risk?

Read more

Glenmark gets US approval for Ashlyna extended-cycle oral contraceptive tablets

Read more

Metropolis Healthcare announces price slash for Swine Flu testing

Read more

A Wait and Watch Approach

Read more

GST and its impact on pharma

Read more

GST: The road ahead

Read more

US FDA raises concerns over Lupin’s plant at Pithampur

Read more

Fortune announces list of 2015 ‘World’s Most Admired Companies’

Read more

Anti-fungal market: In High Gear

Read more

‘We are on track to serve 10,000 customers by mid 2015’

Read more